
Retatrutide
Lyophilised powder — vial
Retatrutide, 99.4% purity, for laboratory research use. A synthetic peptide investigated in vitro and in animal models for agonist activity at GLP-1, GIP, and glucagon receptors.
- Synthetic triple-agonist peptide (GLP-1 / GIP / glucagon receptors)
- ≥ 99.4% purity (HPLC)
- Store lyophilised at −20 °C, protect from light
- Lyophilised powder, single sealed vial
For laboratory research use only. Not for human consumption, therapeutic use, diagnostic application, or veterinary use.
Certificate of Analysis (COA)60 mg
99.4%
1,250 AED
| CAS | 2381089-83-2 |
| Molecular mass | 4731.3 g/mol |
| Molecular formula | C221H342N46O68 |
| Sequence | — |
| Form | Lyophilised powder, single sealed vial |
| Purity | ≥ 99.4% |
| Storage | −20 °C, protect from light |
| COA | Available on request |
Independently third-party tested · COA available on request.
Research Use Only
This product is intended for laboratory research use only. It is not a drug, food, or cosmetic, and is not intended for human or animal use, diagnosis, treatment, cure, or prevention of any disease. By purchasing, you confirm you are a qualified researcher or institution acquiring this material for lawful research purposes.
Related Compounds

Retatrutide
Synthetic triple-agonist peptide (GLP-1 / GIP / glucagon receptors)
650 AED

Retatrutide + Cagrilintide
Triple agonist + amylin analogue blend
Peptide research blend (triple-agonist + amylin analogue)
1,250 AED

Tesamorelin
Synthetic GHRH-analogue peptide
900 AED

AOD-9604
hGH fragment 176-191
Synthetic hGH fragment (176-191)
700 AED
